Catheter Precision shares surge 11.81% intraday after securing Hungary tender for VIVO system, marking first Central European installation.

Catheter Precision (VTAK) surged 11.81% intraday following the announcement that its VIVO system secured a multi-year tender at Szeged University Hospital in Hungary, marking its first installation in the country. The deal, won in partnership with local distributor Fototronic, reinforces the company’s expansion into Central and Eastern Europe and follows recent agreements in France, underscoring the VIVO system’s clinical value and market adoption. The news highlights strategic growth in emerging markets and validates the product’s reputation among electrophysiology experts, aligning with the stock’s sharp intraday rally.